| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 91421-42-0 | 魯比特康; (4S)-4-乙基-4-羥基-10-硝基-1H-吡喃并[3',4':6,7]氮茚并[1,2-b]喹啉-3,14[4H,12H]-二酮 | Rubitecan; (4S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 9-Nitro-20(S)-camptothecin; 9-Nitrocamptothecin; Orathecin |  | C20H15N3O6 | 詳情 | 供應商 |
| 97682-44-5 | 伊立替康; 依立替康; (S)-4,11-二乙基-3,4,12,14-四氫-4-羥基-3,14-二氧代-1H-吡喃并[3',4':6,7]氮茚并[1,2-b | Irinotecan; 1,4'-Bipiperidine-1'-carboxylic acid (S)-4,11-diethyl-3,4,12,14- tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester |  | C33H38N4O6 | 詳情 | 供應商 |
| 100286-90-6 | 鹽酸伊立替康; 鹽酸依立替康 | Irinotecan hydrochloride; (S)-[1,4'-Bipiperidine]-1'-carboxylic acid, 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester hydrochloride |  | C33H38N4O6.HCl | 詳情 | 供應商 |
| 119413-54-6 | 鹽酸拓撲替康; (S)-10-[(二甲基氨基)甲基]-4-乙基-4,9-二羥基-1H-吡喃并[3',4':6,7]氮茚并[1,2-b]-喹啉-3-14 | Topotecan hydrochloride; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione monohydrochloride; Nogitecan hydrochloride; Hycamtin |  | C23H24ClN3O5 | 詳情 | 供應商 |
| 123948-87-8 | 拓撲替康 | Topotecan hydrochloride; 4-Ethyl-4,9-dihydroxy-10-[(dimethylamino)methyl]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione hydrochloride; 9-Dimethylaminomethyl-10-hydroxycamptothecin hydrochloride salt; Hycam |  | C23H23N3O5 | 詳情 | 供應商 |
| 123948-88-9 | 托泊替康醋酸鹽; 醋酸拓撲替康; 4-乙基-4,9-二羥基-10-[(二甲基氨基)甲基]-1H-吡喃并[3',4':6,7]氮茚并[1,2-b | Topotecan acetate; 4-Ethyl-4,9-dihydroxy-10-[(dimethylamino)methyl]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione acetate |  | C23H23N3O5.C2H4O2 | 詳情 | 供應商 |
| 136572-09-3 | 鹽酸伊立替康三水合物; 鹽酸依立替康三水合物 | Irinotecan hydrochloride trihydrate; (S)-[1,4'-Bipiperidine]-1'-carboxylic acid 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester hydrochloride trihydrate |  | C33H38N4O6.HCl.3(H2O) | 詳情 | 供應商 |
| 171335-80-1 | 依喜替康 | Exatecan; (1S,9S)-1-Amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-10H,13H-benzo(de)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-10,13-dione |  | C24H22FN3O4 | 詳情 | 供應商 |
| 292618-32-7 | Gimatecan | Gimatecan; (4S)-11-((E)-((1,1-Dimethylethoxy)imino)methyl)-4-ethyl-4-hydroxy-1,12-dihydro-14H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H)-dione |  | C25H25N3O5 | 詳情 | 供應商 |
| 190710-79-3 | N-DESMETHYL TOPOtecan; N-DESMETHYL TOPOtecan; (4S)-4-Ethyl-4,9-dihydroxy-10-[(methylamino)methyl]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione |  | C22H21N3O5 | 詳情 | 供應商 | |
| 123949-08-6 | Topotecan Carboxylic Acid Sodium Salt; 1-[(Dimethylamino)methyl]-a-ethyl-9,11-dihydro-a,2-dihydroxy-8-(hydroxymethyl)-9-oxo-indolizino[1,2-b]quinoline-7-acetic Acid Monosodium Salt; Topotecan Carboxylic Acid Sodium Salt |  | C23H24N3NaO6 | 詳情 | 供應商 | |
| 104195-61-1 | 9-硝基喜樹堿 | RUBItecan; RUBETICAN; 9-NITRO-CPT; CAMPTOTHECIN, 9-NITRO-20(S)- |  | C20H15N3O6 | 詳情 | 供應商 |
| 1044904-10-0 | TOPOtecan-D6; TOPOtecan-D6; (4S)-10-[[Di(methyl-d3)amino]methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[346-7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; SKF-104864A-d6; (4S)-10-[(Dimethylamino-d6)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3’,4’,6-7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; Hycamtin-d6; NSC-609669-d6 | 無 | C23H20D3N3O5 | 詳情 | 供應商 | |
| 947687-02-7 | Irinotecan IMpurity G; [1,4'-Bipiperidine]-1'-carboxylic Acid (4S)-4,8,11-Triethyl-3,4,12,14- tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl Ester; 8-Ethyl Irinotecan; Irinotecan IMpurity G | 無 | 詳情 | 供應商 | ||
| 186668-70-2 | 二氟替康; 二氟替康 | DIFLOMOtecan |  | C21H16F2N2O4 | 詳情 | 供應商 |
| 169869-90-3 | 伊喜替康甲磺酸鹽 | Exatecan mesylate anhydrous; 伊喜替康甲磺酸鹽 | 無 | 詳情 | 供應商 | |